Iobenzamic acid

Iobenzamic acid represents a noteworthy compound in the domain of radiographic diagnostics. As an organoiodine molecule, it stands out for its role as a contrast medium, assisting healthcare professionals in obtaining high-resolution, clear radiographic images.

Chemical Characteristics[edit | edit source]

The key attribute of iobenzamic acid, like other iodinated contrast agents, is its iodine moiety. Iodine has a unique capability to absorb X-rays effectively, which, when introduced into the body, helps delineate between tissues with different densities, offering enhanced visibility in radiographic imaging^[1].

Clinical Utility[edit | edit source]

Due to its radiopaque nature, iobenzamic acid finds a place in an array of diagnostic imaging applications, including:

The intrinsic capacity of iobenzamic acid to amplify contrast between bodily structures paves the way for clearer and more detailed images, thereby facilitating an accurate diagnosis^[2].

Pharmacokinetics[edit | edit source]

Upon its administration, iobenzamic acid distributes rapidly within the vascular system and, depending on the imaging procedure, might also penetrate interstitial spaces. Typically, the excretion of iodinated contrast agents is through the renal system, necessitating caution and potential dose modifications in patients with renal insufficiencies^[3].

Safety Profile and Side Effects[edit | edit source]

While iobenzamic acid is considered safe for most patients, there are potential side effects and adverse reactions:

Warmth or sensation of heat upon injection
Nausea or vomiting
Flushing

Rare, but more serious side effects could include:

Hypersensitivity or allergic reactions
Contrast-induced nephropathy
Hemodynamic disturbances
It's essential to promptly address any untoward reactions following the administration of the contrast agent^[4].

Conclusion[edit | edit source]

Iobenzamic acid, with its distinct properties and efficacy as a contrast medium, has been pivotal in refining the outcomes of diagnostic imaging. Its targeted use, combined with careful patient monitoring, ensures the acquisition of high-quality images with minimal risks.

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

‎

References[edit | edit source]

Strickland, N. H. (1991). Iodinated contrast media: physical and biological properties. The British Journal of Radiology, 64(767), 923-928.
Van der Molen, A. J., Thomsen, H. S., & Morcos, S. K. (2004). Effect of iodinated contrast media on thyroid function in adults. European Radiology, 14(5), 902-907.
Cohan, R. H., Dunnick, N. R., & Leder, R. A. (1992). Intravascular contrast material administration: guidelines for use and potential complications. Radiographics, 12(1), 173-187.
Thomsen, H. S., Morcos, S. K., & Dawson, P. (2006). Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT: a pooled analysis of two randomized trials. European Radiology, 16(3), 505-511.

↑ Strickland, N. H. (1991). Iodinated contrast media: physical and biological properties. The British Journal of Radiology, 64(767), 923-928.
↑ Van der Molen, A. J., Thomsen, H. S., & Morcos, S. K. (2004). Effect of iodinated contrast media on thyroid function in adults. European Radiology, 14(5), 902-907.
↑ Cohan, R. H., Dunnick, N. R., & Leder, R. A. (1992). Intravascular contrast material administration: guidelines for use and potential complications. Radiographics, 12(1), 173-187.
↑ Thomsen, H. S., Morcos, S. K., & Dawson, P. (2006). Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT: a pooled analysis of two randomized trials. European Radiology, 16(3), 505-511.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

[1] Strickland, N. H. (1991). Iodinated contrast media: physical and biological properties. The British Journal of Radiology, 64(767), 923-928.

[2] Van der Molen, A. J., Thomsen, H. S., & Morcos, S. K. (2004). Effect of iodinated contrast media on thyroid function in adults. European Radiology, 14(5), 902-907.

[3] Cohan, R. H., Dunnick, N. R., & Leder, R. A. (1992). Intravascular contrast material administration: guidelines for use and potential complications. Radiographics, 12(1), 173-187.

[4] Thomsen, H. S., Morcos, S. K., & Dawson, P. (2006). Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT: a pooled analysis of two randomized trials. European Radiology, 16(3), 505-511.

[1]

[2]

[3]

[4]